1. Home
  2. NSP vs SPRY Comparison

NSP vs SPRY Comparison

Compare NSP & SPRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Insperity Inc.

NSP

Insperity Inc.

HOLD

Current Price

$31.73

Market Cap

819.5M

ML Signal

HOLD

Logo ARS Pharmaceuticals Inc.

SPRY

ARS Pharmaceuticals Inc.

HOLD

Current Price

$8.18

Market Cap

833.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NSP
SPRY
Founded
1986
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Professional Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
819.5M
833.1M
IPO Year
1996
2020

Fundamental Metrics

Financial Performance
Metric
NSP
SPRY
Price
$31.73
$8.18
Analyst Decision
Hold
Strong Buy
Analyst Count
3
1
Target Price
$47.67
$40.00
AVG Volume (30 Days)
816.6K
1.4M
Earning Date
04-30-2026
05-13-2026
Dividend Yield
8.30%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$6,812,000,000.00
$84,278,000.00
Revenue This Year
$3.45
$90.76
Revenue Next Year
$6.95
$81.70
P/E Ratio
N/A
N/A
Revenue Growth
3.51
N/A
52 Week Low
$18.57
$6.66
52 Week High
$80.45
$18.63

Technical Indicators

Market Signals
Indicator
NSP
SPRY
Relative Strength Index (RSI) 67.21 47.22
Support Level $31.00 $8.05
Resistance Level $39.86 $8.63
Average True Range (ATR) 1.75 0.37
MACD 0.47 0.05
Stochastic Oscillator 96.55 55.36

Price Performance

Historical Comparison
NSP
SPRY

About NSP Insperity Inc.

Insperity Inc is a company that provides a wide range of human resources and business solutions designed to help businesses improve their performance. Small and midsize enterprises are the company's primary target customers. Majority of the company's products are offered through the company's Workforce Optimization and Workforce Synchronization solutions, which comprise various human resource functions, such as payroll and employment administration, employee benefits and compensation, government compliance, performance management, training and development services, and human capital management. The company generates all of its revenue in the United States.

About SPRY ARS Pharmaceuticals Inc.

ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the commercialization and development of neffy (currently identified in the European Union (EU) and United Kingdom (U.K.) by the trade name EURneffy and in China) for needle-free intranasal delivery of epinephrine for emergency treatment of Type I allergic reactions, including anaphylaxis. Neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows Neffy to safely provide intranasal delivery of epinephrine at a low dose within the exposures of approved injectable products across a range of dosing conditions.

Share on Social Networks: